FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells.
about
Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cellsOxidative stress: Biomarkers and novel therapeutic pathways.Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.The "O" class: crafting clinical care with FoxO transcription factors.Targeting nucleocytoplasmic transport in cancer therapyInflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Nucleo-cytoplasmic transport as a therapeutic target of cancerFoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.Regulation of ubiquitination-mediated protein degradation by survival kinases in cancer.Arsenic trioxide-induced growth arrest of breast cancer MCF-7 cells involving FOXO3a and IκB kinase β expression and localization.Clever cancer strategies with FoxO transcription factors.Opportunities and challenges in combination gene cancer therapy.A fork in the path: Developing therapeutic inroads with FoxO proteins.Androgen receptor signaling in prostate cancer.Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells.Cytokine effects on cell viability and death of prostate carcinoma cells.Forkhead followed by disordered tail: The intrinsically disordered regions of FOXO3a.A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanismsAutophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis.Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL.TNF is necessary for castration-induced prostate regression, whereas TRAIL and FasL are dispensable.Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate.β-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth in vitro and in vivo.
P2860
Q24300910-7BC209F5-7418-4714-B469-25BC4F8E9A26Q33682262-AA5B7D29-C23E-4587-9526-B22C563402DBQ33775726-0C58BB58-8045-47BB-8E17-F9E82331DA80Q33824809-FE57A29B-CBBE-4F2E-8540-3EA50F564137Q34398166-35C7EBC4-2889-4653-A7FF-45AE9BD9D19EQ34450860-649F7F19-852A-49BB-9686-6BDB87122B00Q34452108-B6337D0C-9189-4FC5-BA76-16C44BBC587BQ34666156-7484A7BE-9010-4E29-907F-9B02ED1891A3Q35793871-EB2BE0FB-79FB-4A19-BE4A-0DB34700CF81Q35951059-F8BD2D7B-ACCD-42D4-84A6-8D1107F0F630Q35971560-B94C0DF2-0543-4DFF-B5BC-A9B7B3702EA7Q36305178-FB065D85-B792-4C47-94C3-845B35700E93Q37071395-7E0C61AB-7D0A-4560-AD5B-EF140B9255DBQ37118663-EA4EB993-81C0-4779-9779-244C3270E8AEQ37390262-5C616BF0-5FD0-4D1D-94A9-A22EECB3CA67Q38175320-F23FA8C5-F084-44EB-855A-FB826B9C95B4Q38323902-78E6E825-A6CD-4A72-BDC3-343CE8E99E4AQ38812632-EC7B6968-B42F-4F69-B660-3BB46B3AA558Q38979197-24620399-48E0-415C-B82A-7F52A7FFCC74Q39000854-68BDE255-C90A-476A-BB42-7851EF140F76Q39124486-F23E5B9D-3694-4831-B47F-73F103695C76Q39195907-162CC474-0DCF-4FE9-B640-37FCACBD2AE1Q39290799-98D2B7D9-9602-496D-B0B5-B4EAEEC093E8Q39389293-DF42FC5E-A26F-445E-B7B8-EBA19A30EE85Q42016370-4B95A3CB-3B7A-4AB3-8809-08302C32DED2Q52874494-9F43B545-D25D-4DFC-AB16-399B6AC86BE3Q55319952-29C81694-B8A3-44FB-898F-2BBBADAA5783
P2860
FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
FOXO3a mediates the androgen-d ...... uced apoptosis of LNCaP cells.
@en
FOXO3a mediates the androgen-d ...... uced apoptosis of LNCaP cells.
@nl
type
label
FOXO3a mediates the androgen-d ...... uced apoptosis of LNCaP cells.
@en
FOXO3a mediates the androgen-d ...... uced apoptosis of LNCaP cells.
@nl
prefLabel
FOXO3a mediates the androgen-d ...... uced apoptosis of LNCaP cells.
@en
FOXO3a mediates the androgen-d ...... uced apoptosis of LNCaP cells.
@nl
P2093
P2860
P356
P1433
P1476
FOXO3a mediates the androgen-d ...... uced apoptosis of LNCaP cells.
@en
P2093
A N Cornforth
E Khanifar
J J Krolewski
K L Nastiuk
P2860
P2888
P304
P356
10.1038/ONC.2008.80
P407
P577
2008-04-07T00:00:00Z
P5875
P6179
1031773525